These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15328534)

  • 1. Recognition and accommodation at the androgen receptor coactivator binding interface.
    Hur E; Pfaff SJ; Payne ES; Grøn H; Buehrer BM; Fletterick RJ
    PLoS Biol; 2004 Sep; 2(9):E274. PubMed ID: 15328534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
    Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
    J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of androgen receptor coactivators in prostate cancer.
    Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.
    Hsu CL; Chen YL; Yeh S; Ting HJ; Hu YC; Lin H; Wang X; Chang C
    J Biol Chem; 2003 Jun; 278(26):23691-8. PubMed ID: 12714604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.
    van de Wijngaart DJ; van Royen ME; Hersmus R; Pike AC; Houtsmuller AB; Jenster G; Trapman J; Dubbink HJ
    J Biol Chem; 2006 Jul; 281(28):19407-16. PubMed ID: 16690616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.
    Zhou XE; Suino-Powell KM; Li J; He Y; Mackeigan JP; Melcher K; Yong EL; Xu HE
    J Biol Chem; 2010 Mar; 285(12):9161-71. PubMed ID: 20086010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
    Chang HC; Chen SC; Chen J; Hsieh JT
    J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
    Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
    J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
    He B; Wilson EM
    Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells.
    Yeh S; Kang HY; Miyamoto H; Nishimura K; Chang HC; Ting HJ; Rahman M; Lin HK; Fujimoto N; Hu YC; Mizokami A; Huang KE; Chang C
    Endocrine; 1999 Oct; 11(2):195-202. PubMed ID: 10709768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor.
    Kang HY; Yeh S; Fujimoto N; Chang C
    J Biol Chem; 1999 Mar; 274(13):8570-6. PubMed ID: 10085091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
    Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
    J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2.
    He B; Bowen NT; Minges JT; Wilson EM
    J Biol Chem; 2001 Nov; 276(45):42293-301. PubMed ID: 11551963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
    Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
    Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB; Minges JT; Hnat AT; Wilson EM
    Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.